X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (28592) 28592
Book Review (8326) 8326
Publication (2574) 2574
Newsletter (2565) 2565
Newspaper Article (447) 447
Book Chapter (341) 341
Conference Proceeding (119) 119
Book / eBook (93) 93
Magazine Article (71) 71
Transcript (46) 46
Dissertation (14) 14
Reference (9) 9
Trade Publication Article (9) 9
Web Resource (6) 6
Government Document (3) 3
Streaming Video (3) 3
Report (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (23607) 23607
humans (19378) 19378
animals (11103) 11103
monoclonal antibodies (8693) 8693
female (7793) 7793
male (6446) 6446
oncology (6003) 6003
mice (5824) 5824
pharmacology & pharmacy (5467) 5467
antibodies, monoclonal - therapeutic use (5433) 5433
cancer (5152) 5152
monoclonal-antibody (4381) 4381
antibodies (4366) 4366
middle aged (3855) 3855
research (3638) 3638
adult (3586) 3586
antibodies, monoclonal - pharmacokinetics (3579) 3579
pharmacokinetics (3485) 3485
care and treatment (3252) 3252
immunology (3131) 3131
aged (2982) 2982
treatment outcome (2922) 2922
therapy (2868) 2868
antibodies, monoclonal - administration & dosage (2611) 2611
health aspects (2523) 2523
analysis (2488) 2488
immunotherapy (2479) 2479
clinical trials (2417) 2417
proteins (2393) 2393
monoclonal-antibodies (2280) 2280
drug therapy (2232) 2232
tissue distribution (2170) 2170
tumors (2163) 2163
antibodies, monoclonal, humanized (2147) 2147
antibodies, monoclonal - immunology (2079) 2079
medicine & public health (2036) 2036
chemotherapy (2009) 2009
viral antibodies (1977) 1977
antineoplastic agents - therapeutic use (1962) 1962
antibodies, monoclonal - adverse effects (1937) 1937
antibodies, monoclonal - pharmacology (1871) 1871
expression (1849) 1849
cell line, tumor (1831) 1831
medicine, research & experimental (1817) 1817
monoclonal antibody (1771) 1771
antibody (1733) 1733
immunoglobulins (1727) 1727
medical research (1660) 1660
biological products (1645) 1645
biochemistry & molecular biology (1595) 1595
hematology (1586) 1586
mice, nude (1575) 1575
rats (1560) 1560
article (1554) 1554
safety (1538) 1538
in-vivo (1536) 1536
double-blind (1454) 1454
dose-response relationship, drug (1438) 1438
drugs (1414) 1414
bevacizumab (1382) 1382
clinical trials as topic (1376) 1376
biotechnology & applied microbiology (1365) 1365
antibodies, monoclonal, humanized - therapeutic use (1359) 1359
abridged index medicus (1349) 1349
radioimmunotherapy (1314) 1314
mice, inbred balb c (1293) 1293
pharmacology (1280) 1280
efficacy (1267) 1267
rituximab (1250) 1250
cells (1243) 1243
radiology, nuclear medicine & medical imaging (1234) 1234
infliximab (1223) 1223
neoplasms - drug therapy (1223) 1223
patients (1212) 1212
review (1205) 1205
pharmacology/toxicology (1195) 1195
antineoplastic combined chemotherapy protocols - therapeutic use (1134) 1134
medicine (1134) 1134
antigens (1104) 1104
antibodies, monoclonal - chemistry (1069) 1069
biomedicine (1061) 1061
medicine, experimental (1059) 1059
metastasis (1054) 1054
time factors (1053) 1053
trastuzumab (1052) 1052
binding (1027) 1027
drug delivery systems (1027) 1027
pharmaceutical industry (1005) 1005
enzyme-linked immunosorbent assay (998) 998
studies (996) 996
antineoplastic agents (984) 984
aged, 80 and over (979) 979
immunoglobulin g (968) 968
rheumatoid arthritis (965) 965
breast cancer (959) 959
antineoplastic agents - pharmacology (956) 956
apoptosis (953) 953
reports (950) 950
research article (932) 932
antineoplastic agents - administration & dosage (931) 931
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (46) 46
Collection Dvlpm't (Acquisitions) - Vendor file (8) 8
Online Resources - Online (8) 8
Engineering & Comp. Sci. - Stacks (2) 2
Gerstein Science - Circulation Desk (2) 2
UofT at Mississauga - Stacks (2) 2
Chemistry (A D Allen) - Stacks (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Scarborough Hospital - General (1) 1
Toronto East General Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (31883) 31883
French (59) 59
German (50) 50
Japanese (47) 47
Chinese (31) 31
Spanish (26) 26
Russian (14) 14
Danish (7) 7
Italian (6) 6
Polish (6) 6
Hungarian (2) 2
Korean (2) 2
Portuguese (2) 2
Turkish (2) 2
Czech (1) 1
Dutch (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical & Experimental Immunology, ISSN 0009-9104, 12/2015, Volume 182, Issue 3, pp. 289 - 301
Journal Article
Critical Care Medicine, ISSN 0090-3493, 08/2012, Volume 40, Issue 8, pp. 2320 - 2326
Journal Article
Ophthalmology, ISSN 0161-6420, 2007, Volume 114, Issue 5, pp. 855 - 859
Journal Article
Journal Article
Gastroenterology, ISSN 0016-5085, 2015, Volume 148, Issue 7, pp. 1320 - 1329.e3
Background & Aims Infliximab, a tumor necrosis factor antagonist, is effective for treating patients with Crohn’s disease (CD) and ulcerative colitis (UC). We... 
Gastroenterology and Hepatology | Personalized Medicine | Pharmacokinetics | Therapeutic Drug Monitoring | Monoclonal Antibody | DOSE INTENSIFICATION | MAINTENANCE | THERAPY | CROHNS-DISEASE | EFFICACY | GASTROENTEROLOGY & HEPATOLOGY | ASSOCIATION | WITHDRAWAL | Drug Costs | Recurrence | Crohn Disease - economics | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Gastrointestinal Agents - administration & dosage | Male | Colitis, Ulcerative - immunology | Gastrointestinal Agents - economics | Antibodies, Monoclonal - blood | Drug Dosage Calculations | Anti-Inflammatory Agents - adverse effects | Infliximab | Crohn Disease - diagnosis | Adult | Anti-Inflammatory Agents - administration & dosage | Anti-Inflammatory Agents - pharmacokinetics | Female | Colitis, Ulcerative - drug therapy | Gastrointestinal Agents - pharmacokinetics | Anti-Inflammatory Agents - economics | Tertiary Care Centers | Antibodies, Monoclonal - pharmacokinetics | Treatment Outcome | Colitis, Ulcerative - blood | Crohn Disease - immunology | Remission Induction | Anti-Inflammatory Agents - blood | Algorithms | Belgium | Colitis, Ulcerative - diagnosis | Antibodies, Monoclonal - administration & dosage | Cost-Benefit Analysis | Crohn Disease - blood | Crohn Disease - drug therapy | Gastrointestinal Agents - adverse effects | Gastrointestinal Agents - blood | Colitis, Ulcerative - economics | Drug Monitoring | Antibodies, Monoclonal - economics | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Care and treatment | Continuing medical education | Consulting services | Ulcerative colitis | Index Medicus | Abridged Index Medicus
Journal Article
Science, ISSN 0036-8075, 5/2010, Volume 328, Issue 5981, pp. 1031 - 1035
Poor penetration of anticancer drugs into tumors can be an important factor limiting their effícacy. We studied mouse tumor models to show that a previously... 
Molecules | Intravenous injections | Medical treatment | REPORTS | Antineoplastics | Antibodies | Liposomes | Dosage | Prostate cancer | Tumors | Cancer | NANOPARTICLES | INTEGRINS | MULTIDISCIPLINARY SCIENCES | MOUSE MODEL | IN-VIVO | DOXORUBICIN | PHAGE DISPLAY | VASCULAR-PERMEABILITY FACTOR | CELL | ENDOTHELIAL GROWTH-FACTOR | DELIVERY | Neoplasms - metabolism | Doxorubicin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Neuropilin-1 - metabolism | Albumin-Bound Paclitaxel | Humans | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Capillary Permeability - drug effects | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Paclitaxel - pharmacokinetics | Antineoplastic Agents - administration & dosage | Albumins - therapeutic use | Antibodies, Monoclonal, Humanized | Antineoplastic Agents - pharmacokinetics | Paclitaxel - administration & dosage | Doxorubicin - administration & dosage | Oligopeptides - pharmacokinetics | Antibodies, Monoclonal - pharmacokinetics | Albumins - administration & dosage | Neoplasms - blood supply | Oligopeptides - metabolism | Permeability | Paclitaxel - therapeutic use | Doxorubicin - pharmacokinetics | Neoplasms - drug therapy | Xenograft Model Antitumor Assays | Albumins - pharmacokinetics | Animals | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mice | Oligopeptides - administration & dosage | Oligopeptides - pharmacology | Trastuzumab | Antimitotic agents | Peptides | Research | Antineoplastic agents | Drug therapy | Health aspects | Chemotherapy | Index Medicus | Drugs | Nanoparticles | Side effects | Doxorubicin | Constraining
Journal Article